Healthy Subject Clinical Trial
Official title:
Interactive Diet and Activity Tracking in AARP (IDATA): Biomarker Based Validation Study of Internet-Based and Conventional Self-Report Instruments for Assessing Diet and Physical Activity Within AARP
Verified date | June 2020 |
Source | National Cancer Institute (NCI) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This research trial studies how well internet-based and self-report instruments measure food intake and physical activity levels and their relationship with disease within American Association of Retired Persons (AARP) members. Comparing new internet-based questionnaires developed by the National Cancer Institute that report all the foods consumed and activities performed in an entire day to standardized physical measurements may help to determine if the information collected is accurate.
Status | Completed |
Enrollment | 1130 |
Est. completion date | December 31, 2013 |
Est. primary completion date | December 31, 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 74 Years |
Eligibility |
Exclusion Criteria: - Non-English speaking or reading - Weight loss diet (liquid or medications) - Diabetes - Body mass index < 18.5 or >= 40 (kg/m^2) - History of renal failure, congestive heart failure, or other conditions involving disturbances in fluid balance - Limited mobility - Use of supplemental oxygen - Allergy to para-amino benzoic acid (PABA) - No access to high-speed internet - No more than one AARP member in the household can participate in the study |
Country | Name | City | State |
---|---|---|---|
United States | NCI Division of Cancer Control and Population Sciences | Rockville | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Self-reported energy intake from automated self-administered 24-hour dietary recall (ASA24), Diet History Questionnaire (DHQ)-II, and 4-day food record | Will be evaluated against energy intake measured by doubly labeled water (DLW). Dietary intake of protein, potassium, and other nutrients will be compared to urinary nitrogen (UN), urinary potassium, and other nutrients measured in urine and blood. | Up to 12 months | |
Primary | Measurement error structure of self-reported active and sedentary behaviors (e.g. activity completed over time in 24-hours [ACT24], questionnaires) | Will be examined using energy expenditure measured by DLW, physical activity monitor data, and hear rate monitor data. Data will be also used to evaluate alternative statistical methods for combining different types of self-report data on diet and physical activity-related behaviors as well as self-report plus objectively measured data. | Up to 12 months | |
Primary | 24-hour urine samples | Will be analyzed for UN, potassium, para-amino benzoic acid (PABA), and other nutrients that are potential objective markers of intakes. First morning void urine also will be evaluated for its potential to be used as a source of biomarkers replacing 24-hr urine. Urine will be analyzed to characterize metabolic profiles of individuals. | Up to 12 months | |
Primary | Fasting blood sample analyses | Will be processed to extract plasma and red and white blood cells, and analyzed in the future for vitamin C, folate, vitamin E, vitamin A, carotenoids, lipids, fatty acids and other nutrients. | Up to 12 months | |
Primary | Saliva samples | Will be analyzed for oral microbiomes and to characterize metabolic profiles of individuals. | Up to 12 months | |
Primary | Measurement error structure of self-reported dietary assessment instruments | Evaluated using latent-variable (measurement error) models. The models allow self-reported dietary intake to have intake-related and person-specific biases, but assume that reference biomarkers (doubly-labeled water, urinary nitrogen, urinary potassium) provide unbiased estimates of true usual intake at the individual level. Such models allow one to estimate the joint distribution of true and reported intake, and to estimate parameters of interest such as the correlation of true and reported intake and the "attenuation factor", or slope in the regression of true intake on reported intake. | Up to 12 months | |
Primary | Measurement error in self-reported total physical activity (measured in energy expenditure) | Evaluated using latent-variable (measurement error) models. The models allow total energy expenditure derived from a physical activity monitor to have intake-related and person-specific biases, but assume that reference biomarkers (doubly-labeled water, urinary nitrogen, urinary potassium) provide unbiased estimates of true usual intake at the individual level. Such models to help develop better algorithms for estimating total energy expenditure from the measurements of physical activity monitors. For other physical activity measures of interest, such as minutes of vigorous activity or minutes of sedentary time per day, will use the physical activity monitors to derive approximately unbiased estimates that can be used as reference instruments. | Up to 12 months | |
Primary | Reduction in measurement error | Will use multivariate measurement error models to estimate the joint distribution of true and reported values (nutrient intake, total energy, physical activity, body size). Then calculate residual reported intake (given reported total energy, physical activity and body size) and residual true intake (given true total energy, physical activity and body size), and assess the measurement error properties of reported residual intake as a measure of true residual intake. Specifically, will calculate the correlation of true and reported residual intake and the attenuation factor for residual reported intake and compare them to the same measures calculated for the simpler model that adjusts only for energy. | Up to 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02664883 -
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
|
||
Completed |
NCT05611281 -
GS3-007a Oral Solution in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03457480 -
Text Messages in Preventing Tobacco Use in Young Adults
|
N/A | |
Completed |
NCT05358756 -
A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers
|
Phase 1 | |
Completed |
NCT06037395 -
Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects
|
Phase 1 | |
Active, not recruiting |
NCT04032106 -
HPV Vaccine Intervention for Young Sexual Minority Men
|
N/A | |
Completed |
NCT04062955 -
Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants
|
N/A | |
Recruiting |
NCT03897270 -
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
|
N/A | |
Completed |
NCT01846520 -
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
|
N/A | |
Completed |
NCT02960100 -
mHealth Intervention in Increasing HPV Vaccinations in College Students
|
N/A | |
Completed |
NCT03698318 -
Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts
|
N/A | |
Completed |
NCT05497635 -
A Study of STSA-1002 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT03303846 -
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients
|
N/A | |
Terminated |
NCT05559125 -
A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03584100 -
Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal
|
N/A | |
Recruiting |
NCT05117385 -
The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune)
|
N/A | |
Active, not recruiting |
NCT05660720 -
Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT03188848 -
Dose Escalating Study of BPI-3016 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01908920 -
Osteopathic Manipulative Treatment Effects on High Frequency Parameters in Healthy Subjects
|
N/A | |
Active, not recruiting |
NCT03491176 -
Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
|
N/A |